Addressing Disparities in Care for Patients with DLBCL
 |
Addressing Disparities in Care for Patients with DLBCL CME, CPE James O. Armitage, MD; and Loretta J. Nastoupil, MD |
|
| Release Date: September 21, 2022 Expiration Date: September 21, 2023 |
||
|
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma. In this activity, two experts discuss disparities in care for patients with DLBCL. They will address topics such as barriers in care, participation in clinical trials, and improved treatment landscape. This activity will conclude with a discussion on tools to use for best practice. Provided by MediCom Worldwide, Inc.This activity is supported by educational grants from Bristol Myers Squibb and Genentech, a member of the Roche Group. |
||
| Begin, Earn CreditView Only, No Credit | ||